Systemic resistin is increased in type 2 diabetic patients treated with loop diuretics

Journal of Diabetes and its Complications

Volumn 25, Issue 6, 2011, Pages 377-381

  Bauer, Sabrina ^a   Neumeier, Markus ^a   Wanninger, Josef ^a   Walter, Roland ^a   Kopp, Andrea ^a   Bala, Margarita ^a   Schäffler, Andreas ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Medication; Monocyte; Resistin; Type 2 diabetes mellitus

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; INTERLEUKIN 6; LOOP DIURETIC AGENT; METFORMIN; RESISTIN; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CELLS, CULTURED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FUROSEMIDE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; OVERWEIGHT; RENAL INSUFFICIENCY; RESISTIN; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; UREMIA;

EID: 82955187754     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2011.06.001     Document Type: Article

References (38)

1. L.P. Aristoteli, H.J. Moller, B. Bailey, S.K. Moestrup, and L. Kritharides The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis Atherosclerosis 184 2006 342 347 (Pubitemid 43049718)
2. J. Axelsson, A. Bergsten, A.R. Qureshi, O. Heimburger, P. Barany, F. Lonnqvist, B. Lindholm, L. Nordfors, A. Alvestrand, and P. Stenvinkel Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance Kidney International 69 2006 596 604 (Pubitemid 43164455)
3. J. Axelsson, H.J. Moller, A. Witasp, A.R. Qureshi, J.J. Carrero, O. Heimburger, P. Barany, A. Alvestrand, B. Lindholm, S.K. Moestrup, and P. Stenvinkel Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD American Journal of Kidney Diseases 48 2006 916 925 (Pubitemid 44895371)
4. D.C. Brater Diuretic therapy New England Journal of Medicine 339 1998 387 395 (Pubitemid 28363803)
5. M.S. Burnett, C.W. Lee, T.D. Kinnaird, E. Stabile, S. Durrani, M.K. Dullum, J.M. Devaney, C. Fishman, S. Stamou, D. Canos, S. Zbinden, L.C. Clavijo, G.J. Jang, J.A. Andrews, J. Zhu, and S.E. Epstein The potential role of resistin in atherogenesis Atherosclerosis 182 2005 241 248 (Pubitemid 41267191)
6. M. D'Apolito, X. Du, H. Zong, A. Catucci, L. Maiuri, T. Trivisano, M. Pettoello-Mantovani, A. Campanozzi, V. Raia, J.E. Pessin, M. Brownlee, and I. Giardino Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure Journal of Clinical Investigation 120 2010 203 213
7. C. de Luca, and J.M. Olefsky Inflammation and insulin resistance FEBS Letters 582 2008 97 105 (Pubitemid 50010731)
8. J.N. Fain Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells Vitamins and Hormones 74 2006 443 477
9. M. Gerber, A. Boettner, B. Seidel, A. Lammert, J. Bar, E. Schuster, J. Thiery, W. Kiess, and J. Kratzsch Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance Journal of Clinical Endocrinology and Metabolism 90 2005 4503 4509 (Pubitemid 41159333)
10. M.Y. Gharibeh, G.M. Al Tawallbeh, M.M. Abboud, A. Radaideh, A.A. Alhader, and O.F. Khabour Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients Diabetes & Metabolism 36 2010 443 449
11. A. Giulietti, E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory Diabetes Research and Clinical Practice 77 2007 47 57 (Pubitemid 46590467)
12. L.K. Heilbronn, J. Rood, L. Janderova, J.B. Albu, D.E. Kelley, E. Ravussin, and S.R. Smith Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects Journal of Clinical Endocrinology and Metabolism 89 2004 1844 1848 (Pubitemid 38507943)
13. A. Karbowska, M. Boratynska, and M. Klinger Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation? Postepy Higieny I Medycyny Doswiadczalnej (Online) 63 2009 485 491
14. S. Kaser, A. Kaser, A. Sandhofer, C.F. Ebenbichler, H. Tilg, and J.R. Patsch Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro Biochemical and Biophysical Research Communication 309 2003 286 290 (Pubitemid 37025889)
15. M. Laudes, F. Oberhauser, D.M. Schulte, S. Freude, R. Bilkovski, J. Mauer, G. Rappl, H. Abken, M. Hahn, O. Schulz, and W. Krone Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans Hormone and Metabolic Research 42 2010 268 273
16. J.H. Lee, J.L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, R. Seip, C. Orlova, and C.S. Mantzoros Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects Journal of Clinical Endocrinology and Metabolism 88 2003 4848 4856 (Pubitemid 37357535)
17. P.G. McTernan, C.M. Kusminski, and S. Kumar Resistin Curr Opin Lipidol 17 2006 170 175
18. H.J. Moller, R. Frikke-Schmidt, S.K. Moestrup, B.G. Nordestgaard, and A. Tybjaerg-Hansen Serum soluble CD163 predicts risk of type 2 diabetes in the general population Clinical Chemistry 57 2011 291 297
19. G.D. Norata, M. Ongari, K. Garlaschelli, S. Raselli, L. Grigore, and A.L. Catapano Plasma resistin levels correlate with determinants of the metabolic syndrome European Journal of Endocrinology 156 2007 279 284 (Pubitemid 46554524)
20. L. Patel, A.C. Buckels, I.J. Kinghorn, P.R. Murdock, J.D. Holbrook, C. Plumpton, C.H. Macphee, and S.A. Smith Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochemical and Biophysical Research Communication 300 2003 472 476 (Pubitemid 38375833)
21. M. Qatanani, N.R. Szwergold, D.R. Greaves, R.S. Ahima, and M.A. Lazar Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice Journal of Clinical Investigation 119 2009 531 539
22. A. Schaffler, C. Buchler, U. Muller-Ladner, H. Herfarth, A. Ehling, G. Paul, J. Scholmerich, and B. Zietz Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus Hormone and Metabolic Research 36 2004 702 707 (Pubitemid 39486971)
23. A. Schaffler, J. Scholmerich, and C. Buchler Mechanisms of disease: adipocytokines and visceral adipose tissue - emerging role in nonalcoholic fatty liver disease Nature Clinical Practice Gastroenterology & Hepatology 2 2005 273 280 (Pubitemid 40895403)
24. F. Schober, M. Neumeier, J. Weigert, S. Wurm, J. Wanninger, A. Schaffler, A. Dada, G. Liebisch, G. Schmitz, C. Aslanidis, and C. Buechler Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release Biochemical and Biophysical Research Communication 361 2007 968 973 (Pubitemid 47259030)
25. J.V. Silha, M. Krsek, J.V. Skrha, P. Sucharda, B.L. Nyomba, and L.J. Murphy Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance European Journal of Endocrinology 149 2003 331 335 (Pubitemid 37304704)
26. Silha, J. V.; & Murphy, L. J. (2004). Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism, 89, 1977; author reply 1977-1978.
27. D. Sporrer, M. Weber, J. Wanninger, J. Weigert, M. Neumeier, F. Stogbauer, E. Lieberer, M. Bala, A. Kopp, A. Schaffler, and C. Buechler Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity European Journal of Clinical Investegation 39 2009 671 679
28. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, and M.A. Lazar The hormone resistin links obesity to diabetes Nature 409 2001 307 312 (Pubitemid 32151228)
29. F. Stogbauer, M. Neumeier, J. Weigert, J. Wanninger, M. Grandl, K. Lehle, G. Schmitz, C. Aslanidis, A. Schaffler, J. Scholmerich, and C. Buechler Highly efficient and low-cost method to isolate human blood monocytes with high purity Journal of Immunological Methods 337 2008 78 80
30. Y. Takata, H. Osawa, M. Kurata, M. Kurokawa, J. Yamauchi, M. Ochi, W. Nishida, T. Okura, J. Higaki, and H. Makino Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes Hypertension 51 2008 534 539 (Pubitemid 351156444)
31. Y. Takeishi, T. Niizeki, T. Arimoto, N. Nozaki, O. Hirono, J. Nitobe, T. Watanabe, N. Takabatake, and I. Kubota Serum resistin is associated with high risk in patients with congestive heart failure - a novel link between metabolic signals and heart failure Circulation Journal 71 2007 460 464
32. P.C. Tsiotra, C. Tsigos, E. Yfanti, E. Anastasiou, M. Vikentiou, K. Psarra, C. Papasteriades, and S.A. Raptis Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women Hormone and Metabolic Research 39 2007 758 763 (Pubitemid 350103437)
33. J. Weigert, M. Neumeier, J. Wanninger, S. Bauer, S. Farkas, M.N. Scherer, A. Schnitzbauer, A. Schaffler, C. Aslanidis, J. Scholmerich, and C. Buechler Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes Journal of Clinical Endocrinology and Metabolism 95 2010 1404 1411
34. J. Weigert, M. Neumeier, J. Wanninger, M. Filarsky, S. Bauer, R. Wiest, S. Farkas, M.N. Scherer, A. Schaffler, C. Aslanidis, J. Scholmerich, and C. Buechler Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes Clinical Endocrinology (Oxf) 72 2010 342 348
35. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr Obesity is associated with macrophage accumulation in adipose tissue Journal of Clinical Investigation 112 2003 1796 1808 (Pubitemid 38063703)
36. R. Wiest, L. Moleda, S. Farkas, M. Scherer, A. Kopp, U. Wonckhaus, C. Buchler, J. Scholmerich, and A. Schaffler Splanchnic concentrations and postprandial release of visceral adipokines Metabolism 59 2010 664 670
37. B.S. Youn, K.Y. Yu, H.J. Park, N.S. Lee, S.S. Min, M.Y. Youn, Y.M. Cho, Y.J. Park, S.Y. Kim, H.K. Lee, and K.S. Park Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus Journal of Clinical Endocrinology and Metabolism 89 2004 150 156 (Pubitemid 38183874)
38. A. Yuengsrigul, T.W. Chin, and E. Nussbaum Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells Annals of Allergy Asthma & Immunology 83 1999 559 566 (Pubitemid 30013516)